Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

71.48 +0.28 (+0.40%)
Streaming Delayed Price Updated: 12:21 PM EDT, Mar 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
25 26 Next >
News headline image
Why Medical Devices Behemoth Boston Scientific Shares Are Rising Friday ↗
Boston Scientific Corporation (NYSE: BSX) said it expects FARAPULSE Pulsed Field Ablation (PFA) System to get  
Via Benzinga
News headline image
NYSE:BSX may be ready to breakout. ↗
BOSTON SCIENTIFIC CORP (NYSE:BSX) Reveals Intriguing Technical Aspects. Here's What You Need to Know. 
Via Chartmill
News headline image
Show Me The Money: Inside Ken Griffin's Citadel's Jaw-Dropping $7 Billion Return ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗
 
Via Benzinga
News headline image
(BSX) - Analyzing Boston Scientific's Short Interest ↗
 
Via Benzinga
News headline image
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch ↗
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
News headline image
What 18 Analyst Ratings Have To Say About Boston Scientific ↗
 
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗
 
Via Benzinga
News headline image
Uncovering Noteworthy Technical Analysis Findings for BOSTON SCIENTIFIC CORP (NYSE:BSX). ↗
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP. 
Via Chartmill
News headline image
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest Holdings ↗
These two stocks and one ETF helped the billionaire's hedge fund make a boatload of money in 2023. 
Via The Motley Fool
Topics ETFs
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
News headline image
Peering Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
3 Healthcare Stocks to Pick Up Before the Year-End Rally ↗
Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending 
Via InvestorPlace
News headline image
Will Boston Scientific Corporation (BSX) Continue Further upside? ↗
Boston Scientific Corporation (BSX​​​​​​​) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular... 
Via Talk Markets
News headline image
Expert Ratings for Boston Scientific ↗
 
Via Benzinga
News headline image
A Look Into Boston Scientific Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Looking Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Could Ozempic Harm These 3 Medical Device Stocks? ↗
The drug is on track to cause massive competitive shifts in the healthcare sector. 
Via The Motley Fool
News headline image
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape ↗
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations. 
Via InvestorPlace
News headline image
Stryker Stock Elevated To Top Tier Rating; Fresh Base Forming ↗
Stryker also has a healthy B+ Accumulation/Distribution Rating, showing big investors like mutual funds are fairly heavy buyers of its stock. 
Via Investor's Business Daily
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
Via AB Newswire
News headline image
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
News headline image
Medical Devices Provider Boston Scientific Cardiovascular Segment Sees Traction In Q3, Company Adjusts Annual Outlook ↗
Boston Scientific Corp (NYSE: BSX) generated Q3 revenues of $3.53 billion, beating the Wall Street estimate of $3.48 billion. 
Via Benzinga
News headline image
Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter Beat ↗
The company also raised its outlook for the full year. 
Via Investor's Business Daily
News headline image
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem ↗
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in. 
Via Benzinga
News headline image
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
News headline image
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.